The concept of innovative drugs repeatedly strong, Asia-Pacific Pharmaceuticals and other stocks limit up

Innovative drug concept has been repeatedly strong recently, with Asia-Pacific Pharmaceutical and Lianhuan Pharmaceutical both hitting the limit up for two consecutive days. Previously, Chenxin Pharmaceutical and Zhongsheng Pharmaceutical also hit the limit up, while Sanyuan Genetics and Guangshengtang rose more than 10%, and many stocks such as Microlife Biology, Xin Nuowei, and Yaoshi Technology rose more than 7%.